4//SEC Filing
Relypsa Inc 4
Accession 0001140361-16-068994
CIK 0001416792operating
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 6:48 PM ET
Size
9.1 KB
Accession
0001140361-16-068994
Insider Transaction Report
Form 4
Relypsa IncRLYP
Berman Lance
Chief Medical Officer and SVP
Transactions
- Tax Payment
Common Stock
2016-06-03$19.96/sh−783$15,629→ 22,590 total - Award
Common Stock
2016-06-03+2,083→ 23,373 total - Award
Stock Option (Right to Buy)
2016-06-03+8,333→ 8,333 totalExercise: $18.87From: 2016-06-03Exp: 2025-11-06→ Common Stock (8,333 underlying)
Footnotes (3)
- [F1]On November 6, 2015, the Reporting Person was granted 6,250 Restricted Stock Units to vest in three equal tranches upon achievement of certain performance-based milestones (the "Performance RSUs"). On June 3, 2016, the Compensation Committee certified the achievement of the first performance milestone resulting in vesting of 1/3rd of the Performance RSUs.
- [F2]Includes 20,125 Restricted Stock Units.
- [F3]On November 6, 2015, the Reporting Person was granted an option to purchase 25,000 shares of Common Stock to vest in three equal tranches upon achievement of certain performance-based milestones (the "Performance Option"). On June 3, 2016, the Compensation Committee certified the achievement of the first performance milestone resulting in vesting of 1/3rd of the Performance Option.
Documents
Issuer
Relypsa Inc
CIK 0001416792
Entity typeoperating
Related Parties
1- filerCIK 0001416792
Filing Metadata
- Form type
- 4
- Filed
- Jun 6, 8:00 PM ET
- Accepted
- Jun 7, 6:48 PM ET
- Size
- 9.1 KB